One-Pot NASBA Nucleic Acid Detection for Point-of-Care Testing
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current nucleic acid detection methods, such as nested Mango-NASBA assays, do not meet the criteria of rapidity, simplicity, and portability for point-of-care diagnostics, requiring multiple steps and pre-treatment of samples.
Innovation Solution
A modified NASBA method that performs two nested amplification steps in parallel in a single tube, using controlled reagent amounts and T3 RNA polymerase, with conditions like pH 6.8-9.0 and fixed temperature, enabling a single-step, single-vessel reaction that detects nucleic acids in saliva without pre-treatment.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If nested Mango-NASBA assays are performed with multiple steps and pre-treatment, then detection sensitivity is improved, but test complexity and time are increased
Solution Approach 1:
The patent combines two nested amplification steps into a single reaction tube performed simultaneously, eliminating the need for separate pre-treatment and amplification steps. This merging approach maintains detection sensitivity while reducing test complexity and procedure time, directly resolving the contradiction between sensitivity and complexity.
Solution Approach 2:
The invention creates a universal detection system that can detect multiple pathogens (SARS-CoV-2, Influenza A, Influenza B, RSV) using a single reagent mixture and reaction protocol. This multi-functional approach eliminates the need for pathogen-specific pre-treatment steps while maintaining high detection sensitivity across different targets.
2Measurement precision
If RT-PCR is performed with specialized equipment and laboratory transport, then detection sensitivity reaches gold standard levels, but rapidity and portability are lost
Solution Approach 1:
The patent employs a self-heating reaction system where the chemical reagents themselves generate the required temperature for amplification without external thermocyclers. This self-service mechanism enables the test to be performed at point-of-care settings with portable equipment while achieving sensitivity comparable to laboratory-based RT-PCR.
Solution Approach 2:
The invention replaces the mechanical thermocycling system with a chemical heating system using reagent-based temperature generation. This substitution eliminates the need for specialized thermocycler equipment and laboratory infrastructure, enabling rapid portable testing while maintaining detection sensitivity.
3Speed
If RT-LAMP is performed with pH change readout, then test speed is improved, but detection sensitivity deteriorates
Solution Approach 1:
The patent incorporates fluorescent dyes that change emission properties upon binding to amplified nucleic acid products. This optical readout mechanism provides real-time detection during the rapid isothermal amplification process, maintaining both the speed advantage of RT-LAMP and improving sensitivity through specific fluorescent signal detection.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method achieves rapid, portable, and adaptable nucleic acid detection suitable for various settings, with improved sensitivity and specificity, capable of detecting multiple pathogens in a single reaction.
Implementation Method 1
at least one of the primers comprises a fluorescent molecule; detecting the target nucleic acid sequence, wherein a fluorescent signal indicates the presence of the target nucleic acid sequence in the sample
Implementation Method 2
one or more polymerases; amplifying the target nucleic acid sequence by nucleic acid sequence based amplification (NASBA)
Data Source
AI summary
The invention relates to nucleic acid detection, and particularly, although not exclusively, to rapid, one-pot, single-step methods and associated kits for amplifying and detecting target nucleic acid sequences in a sample obtained from a subject. The methods and kits can be used to detect pathogenic nucleic acid sequences in a sample, such as a blood or saliva sample, via the selective amplification of the target nucleic acids, to provide a point of care diagnosis for infectious diseases, or other RNA-related diseases, such as cancer.